Cancer Therapy
Use of biphosphonates in advanced prostate and renal cell cancer discussed
Published in Vaccine Weekly, April 19th, 2006
According to recent research published in the journal Urologia Internationalis, "This review summarizes recent findings on the therapeutic benefits of biphosphonates in patients with advanced prostate or RCC. The role of biphosphonates in ADT-induced osteoporosis and delay of skeletal-related events (SREs) in metastatic bone disease is discussed."
"A brief overview on the proposed modes of action is given. Literature search of PubMed documented publications and abstracts from meetings [was conducted]. Among the biphosphonates currently available,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-04-19)
More Articles from Vaccine Weekly
- Chlamydia Vaccine
Chlamydia trachomatis major outer membrane protein induces partial protection - Chronic Viral Infection
In chronic viral infection, blocking antibodies restore function in exhausted CD8 cells - Immunotherapy
Measles, mumps, rubella, and varicella vaccine can replace second-dose vaccinations - Klebsiella Vaccine
Two immunogenic proteins may be potential Klebsiella pneumoniae vaccine candidates - SARS Vaccine
Anti-SARS-CoV immunity is induced by a novel CpG oligodeoxynucleotide - Animal Tuberculosis
Chembio edges closer to entering the $50 million veterinary TB market - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
